Glaucoma is one of the leading causes of permanent blindness in the world, affecting more than two million Americans, and more than one hundred million people worldwide. It is a disease of the optic ...

Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD. Jonathan Eisengart, MD, an ophthalmologist at Cleveland Clinic, explained how different ...

Scientists are testing a new laser surgery device specifically designed to make glaucoma procedures safer, simpler and faster. The revolutionary non-penetrating technique will be easily mastered by ...

We all want perfect vision. And, to be honest, most of us after a certain age will happily settle for better vision. And that ...

Please provide your email address to receive an email when new articles are posted on . Frailty and older age are associated with significantly lower odds of undergoing surgery or laser treatment for ...

Please provide your email address to receive an email when new articles are posted on . Glaucoma can be a difficult management problem in a subset of patients, even for the most experienced glaucoma ...

Glaucoma is a group of conditions that affect the functioning of the optic nerve, the nerve bundle that connects the eye to the brain. The most common form of glaucoma involves increased pressure ...

Major surgeries such as trabeculectomy and shunts aren't the only options for treating glaucoma when medicines and laser treatments don't work. Minimally invasive surgery is at the forefront of newer ...

ViaLase, a medical technology startup developing a new femtosecond laser treatment for glaucoma, has closed its series C funding round with $40 million in additional finance. Based in Alisa Viejo, ...

Glaucoma is a serious, lifelong eye disease that can lead to vision loss if not controlled. But for most people, glaucoma does not have to lead to blindness. That is because glaucoma is controllable ...

LOS ANGELES & MUNICH--(BUSINESS WIRE)--ELT Sight, Inc. today announced the company has acquired the IP and assets of MLase AG’s excimer ophthalmic laser system for glaucoma surgery. MLase manufactures ...